0001062993-22-010494.txt : 20220420 0001062993-22-010494.hdr.sgml : 20220420 20220420160301 ACCESSION NUMBER: 0001062993-22-010494 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220418 FILED AS OF DATE: 20220420 DATE AS OF CHANGE: 20220420 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kumar Ramesh CENTRAL INDEX KEY: 0001580074 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36751 FILM NUMBER: 22838027 MAIL ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ocugen, Inc. CENTRAL INDEX KEY: 0001372299 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 263 GREAT VALLEY PARKWAY CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 484-328-4701 MAIL ADDRESS: STREET 1: 263 GREAT VALLEY PARKWAY CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: HISTOGENICS CORP DATE OF NAME CHANGE: 20060810 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2022-04-18 0001372299 Ocugen, Inc. OCGN 0001580074 Kumar Ramesh C/O OCUGEN, INC. 263 GREAT VALLEY PARKWAY MALVERN PA 19355 1 0 0 0 Common Stock 2022-04-18 4 M 0 7500 0.51 A 7500 D Common Stock 2022-04-18 4 S 0 7500 2.83 D 0 D Option (Right to Buy) 0.51 2022-04-18 4 M 0 7500 0 A 2030-01-02 Common Stock 7500 16500 D This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.79 to $2.89. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The options, initially representing a right to purchase 54,000 shares, vest and become exercisable in equal monthly installments over three years commencing on February 2, 2020, subject to continued service with the Company on the applicable vesting dates. Ramesh Kumar by Shankar Musunuri, his attorney-in-fact 2022-04-20